Project Grant HT94252410729
Award Date
9/15/24
Completion Date
9/14/27
Dollars Obligated
$541K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Pittsburgh, PA 15260, USA
Similar Awards
This $380,785 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Pittsburgh. The award provides funding for a 3-year research project titled "MICROPARTICLE DELIVERY OF CHEMOKINE MUTEINS GUIDING CHEMOKINE RECEPTOR ENGINEERED TREG FOR TOLERANCE INDUCTION AFTER VASCULAR COMPOSITE ALLOGRAFT TRANSPLANT." The project aims to develop a microparticle-based delivery system to administer...
The University of Pittsburgh was awarded a $1,572,933 federal Project Grant under the Military Medical Research and Development program (CFDA 12.420) by the Defense Health Agency. The grant, effective January 1, 2025 through December 31, 2028, supports advanced biomedical research aimed at "Targeting Lysosomal Pathways to Improve Host Immunity Post Coronaviral Infections." This research aligns with the program's objective to transform healthcare for military service members,...
The University of Pittsburgh was awarded a $313,304 Project Grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) on July 1, 2024. The purpose of this 2-year grant is to conduct research on "Endothelial-Targeted Metallothionein Gene Editing to Enable VEGF Therapy in Rescuing Diabetic Pressure Ulcers." The project aims to develop new treatments for diabetic pressure ulcers by investigating gene editing techniques to enhance the...
The University of Pittsburgh received a $4,902,315 project grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on June 1, 2025, with a completion date of May 31, 2029, is funding research to understand the effects of intracavitary conditioning in breast cancer metastatic to the pleura or the peritoneum. This research aims to transform healthcare for military service members, veterans, and the broader public by...
The University of Pittsburgh was awarded a $2,806,431.00 Project Grant on July 1, 2023 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to optimize small molecule therapeutics to treat focal segmental glomerulosclerosis. This basic, applied, and advanced biomedical research aims to transform health care by developing innovative and impactful medical solutions for Service Members and the American public. The University of Pittsburgh will...
This $1,264,474 federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the University of Pittsburgh's research on "Molecular Insights into Immune Suppression in Kidney Cancer and Novel Therapeutic Opportunities". The grant, effective September 1, 2024 through August 31, 2028, will fund the university's investigations into improving understanding of immune system mechanisms involved in kidney cancer and...
The University of Pittsburgh has been awarded a $747,131 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 10, 2024, supports the development of an Extracorporeal Perfusion System (EPS) for composite tissue regeneration. This research effort aims to advance innovative medical technologies to improve health outcomes for military service members and the broader public. The grant will fund a...
The University of Pittsburgh has been awarded a $681,379 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to evaluate B-T cell cross talk within tertiary lymphoid structures in melanoma progression and immune checkpoint blockade. The award has a performance period from July 1, 2024 to June 30, 2027. This research project aims to enhance understanding of the immune processes involved in melanoma development and response to...
The University of Pittsburgh has been awarded a $1,541,823 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development federal grant program (CFDA 12.420) to develop fast treatment methods for metastatic cancer patients with pleural disease. The grant, which runs from November 1, 2024 to October 31, 2028, will fund the University's research efforts to explore innovative approaches to disease prevention, diagnosis, treatment, and management of these...
The University of Pittsburgh - Of The Commonwealth System of Higher Education, doing business as The University of Pittsburgh, received a $724,997.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the project "RECOVERY OF TENDON INJURY BY TARGETING ITS ROOT CAUSE AND ENHANCING TENDON STEM CELLS." The grant period of performance is from July 1, 2023 to June 30, 2026. The project aims to conduct biomedical...